LI-RADS: looking back, looking forward

V Chernyak, KJ Fowler, RKG Do, A Kamaya, Y Kono… - Radiology, 2023 - pubs.rsna.org
Since its initial release in 2011, the Liver Imaging Reporting and Data System (LI-RADS)
has evolved and expanded in scope. It started as a single algorithm for hepatocellular …

[HTML][HTML] Prognosis prediction of hepatocellular carcinoma based on magnetic resonance imaging features

HM Low, JM Lee, CH Tan - Korean Journal of Radiology, 2023 - ncbi.nlm.nih.gov
• Current staging systems for hepatocellular carcinoma (HCC) are centered on treatment
decisions and based on prognosis determined by a combination of imaging, laboratory, and …

Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI‐RADS)

V Chernyak, KJ Fowler, JP Heiken… - Journal of Magnetic …, 2019 - Wiley Online Library
Use of gadoxetate disodium, a hepatobiliary gadolinium‐based agent, in patients with
chronic parenchymal liver disease offers the advantage of improved sensitivity for detecting …

Apparent diffusion coefficient as a potential marker for tumour differentiation, staging and long-term clinical outcomes in gallbladder cancer

JH Min, TW Kang, DI Cha, SH Kim, KS Shin, JE Lee… - European …, 2019 - Springer
Objectives To evaluate the correlation between tumour differentiation or stage of gallbladder
cancer (GBC) and the apparent diffusion coefficient (ADC), as well as to assess whether …

Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade

MQ Cheng, HT Hu, H Huang, JM Pan, MF Xian… - European …, 2021 - Springer
Objectives To evaluate the influence of pathological factors, such as fibrosis stage and
histological grade, on the Liver Imaging Reporting and Data System (LI-RADS) v2017 …

[HTML][HTML] Gadoxetate-enhanced MRI as a diagnostic tool in the management of hepatocellular carcinoma: report from a 2020 Asia-Pacific multidisciplinary expert …

CH Tan, S Chou, N Inmutto, K Ma… - Korean Journal of …, 2022 - ncbi.nlm.nih.gov
Gadoxetate magnetic resonance imaging (MRI) is widely used in clinical practice for liver
imaging. For optimal use, we must understand both its advantages and limitations. This …

Up-to-Date Role of Liver Imaging Reporting and Data System in Hepatocellular Carcinoma

V Chernyak - Surgical Oncology Clinics, 2024 - surgonc.theclinics.com
Up-to-Date Role of Liver Imaging Reporting and Data System in Hepatocellular Carcinoma -
Surgical Oncology Clinics Skip to Main Content Advertisement Surgical Oncology Clinics …

[HTML][HTML] Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase …

N Brandi, M Renzulli - Journal of Clinical and Translational …, 2024 - ncbi.nlm.nih.gov
Recent technical advances in liver imaging and surveillance for patients at high risk for
developing hepatocellular carcinoma (HCC) have led to an increase in the detection of …

Liver Cancer Confirmation by Contrast‐Enhanced Ultrasound Coupled With Magnetic Resonance Imaging: Case Report of Liver Inflammation Misdiagnosed as …

H Tu, L Chen, J Lin, J Wang - Journal of Ultrasound in …, 2020 - search.ebscohost.com
Abstract Liver Cancer Confirmation by Contrast-Enhanced Ultrasound Coupled With
Magnetic Resonance Imaging: Case Report of Liver Inflammation Misdiagnosed as Atypical …

Association between intensity of imaging surveillance and clinical outcomes in patients with hepatocellular carcinoma

JA Hwang, TW Kang, JH Min, YK Kim, SH Kim… - European Journal of …, 2022 - Elsevier
Background The role of computed tomography (CT)/magnetic resonance imaging (MRI)
surveillance for hepatocellular carcinoma (HCC) is unclear. We aimed to determine whether …